Request Trial
shutterstock_647031994_romanr
romanr / Shutterstock.com
22 February 2019Americas

ResMed and Fisher & Paykel settle patent disputes

American medical device maker  ResMed and New Zealand-based competitor  Fisher & Paykel have agreed to settle a global patent dispute over medical devices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026   Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.
Americas
J&J unit targets former employee over alleged mass data theft
17 March 2026   Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios.
Americas
Six Summit takeaways: In-person IP, agentic AI and ‘infollution’ risks
12 March 2026   The event unpacked how technology, litigation trends, and global events are adding complexity while also offering benefits for legal teams under pressure to reduce costs.


Editor's picks

Masimo convinces judge that Apple took secrets—but it’s not enough
Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026

Editor's picks

Americas
Masimo convinces judge that Apple took secrets—but it’s not enough
19 March 2026

More features

Masimo convinces judge that Apple took secrets—but it’s not enough
Sandoz strikes fresh biosimilar deal with South Korean biotech
US firm boosts patent bench with Desmarais hire
J&J unit targets former employee over alleged mass data theft
HSF Kramer hires patent litigator as partner in Germany
INTA: ‘New normal’ for in-house counsel as budgets fall
Mylan withdraws defence claims against Novo in Wegovy dispute
Six Summit takeaways: In-person IP, agentic AI and ‘infollution’ risks